RecruitingNot ApplicableNCT07725601

VNS Algorithm for Advanced Dosing

VNS Algorithm for Advanced Dosing: Example Guided Mode Titrations "The Augusta Way"

Sponsor

Fernando Vale

Enrollment

80 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Epilepsies

Summary

The goal of this clinical trial is to compare the standard programming of the VNS device (Control) to a modified programming (Augusta Way) in adults with epilepsy. The main question it aims to answer is: Does the modified programming of the VNS reduce seizures faster than the standard programming? Participants in both groups will: 1. Attend up to 3 study visits every 3 months for 2 years 2. Answer questionnaires to assess quality of life and cognitive function 3. Maintain a diary of seizure activity

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Rapid Titration VNS programming and a medical device called Standard VNS programming for people with epilepsies. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERapid Titration VNS programming

Modified programming of VNS that provides rapid titration

DEVICEStandard VNS programming

Standard of Care VNS programming

Locations(1)

Wellstar MCG Hospital

Augusta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07725601

Related Trials

Chinese-Specific Speech Imagery Coding Using High-Density ECoG

NCT074600371 location

Home Ultra-long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic Encephalopathies

NCT068559014 locations